Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Vir Biotechnology Inc. (VIR)

16.26   -0.65 (-3.84%) 02-21 16:00
Open: 16.91 Pre. Close: 16.91
High: 17 Low: 16.09
Volume: 159,429 Market Cap: 1639M
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products for the treatment and prevention of serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus, and VIR-2020 for the prevention of tuberculosis. The company has grant agreement with Bill & Melinda Gates Foundation and National Institutes of Health; option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; collaboration and license agreement Alnylam Pharmaceuticals, Inc.; collaboration, license and option agreement Visterra, Inc.; and license agreement with The Rockefeller University and MedImmune, Inc. It operates in the United States, Oregon, Massachusetts, and Switzerland. The company was founded in 2016 and is headquartered in San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 17.036 - 17.139 17.139 - 17.215
Low: 15.853 - 15.985 15.985 - 16.082
Close: 16.087 - 16.281 16.281 - 16.426

Technical analysis

as of: 2020-02-21 4:34:54 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 27.82     One year: 33.87
Support: Support1: 15.44    Support2: 12.85
Resistance: Resistance1: 23.82    Resistance2: 29.00
Pivot: 19.39
Moving Average: MA(5): 17.04     MA(20): 20.14
MA(100):     MA(250):
MACD: MACD(12,26):     Signal(9): 0.75
Stochastic oscillator: %K(14,3): 2.05     %D(3): 2.79
RSI: RSI(14): 43.48
52-week: High: 29.00  Low: 11.65  Change(%): 16.0
Average Vol(K): 3-Month: 33102  10-Days: 24118

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
VIR has closed above bottom band by 20.7%. Bollinger Bands are 0% narrower than normal.

Headline News

Thu, 06 Feb 2020 15:50:43 +0000
7 Biotech Stocks to Buy That Could Beat the Coronavirus

Mon, 03 Feb 2020 19:29:00 +0000
Here's Why Inovio Pharmaceuticals and Vir Biotechnology Shares Have Fallen Today

Thu, 30 Jan 2020 21:29:58 +0000
World Health Organization Classifies Wuhan Coronavirus as International Health Emergency

Thu, 30 Jan 2020 20:40:40 +0000
Health Care Sector Update for 01/30/2020: OPGN,VTGN,VIR,ALBO

Thu, 30 Jan 2020 17:53:39 +0000
Health Care Sector Update for 01/30/2020: VTGN,VIR,ALBO

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector: 
Industry: 
Shares Out. (M) 109.68
Shares Float (M) 37.64
% Held by Insiders 0.43
% Held by Institutions
Shares Short (K) 1240
Shares Short P. Month (K)

Stock Financials

EPS -14.640
Book Value (p.s.) -23.940
PEG Ratio
Profit Margin
Operating Margin -1380.75
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth -51.4
Gross Profit (p.s.) -0.817
Sales Per Share
EBITDA (p.s.) -1.260
Qtrly Earnings Growth
Operating Cash Flow (M) -120.25
Levered Free Cash Flow (M)

Stock Valuations

P/E -1.11
P/E Growth Ratio -0.04
P/BV -0.68
P/S 14.91
P/CF -14.83

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.